BVT.ST: Summary for BIOVITRUM - Yahoo! Canada Finance - Share Prices, Charts, News and more

MORE ON BVT.ST

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BIOVITRUM (Stockholm:BVT.ST) Delayed quote data

Last Trade:	31.70 SEK
Trade Time:	6:07AM EST
Change:	0.90 (2.76%)
Prev Close:	32.60
Open:	32.80
Bid:	31.70
Ask:	31.80
1y Target Est:	N/A

Day's Range:	31.50 - 32.80
52wk Range:	24.70 - 73.00
Volume:	104,995
Avg Vol (3m):	488,052
Market Cap:	N/A
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add BVT.ST to Portfolio

Download Data

HEADLINES

•	Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B Therapy
	Business Wire (Mon, Jan 25)

•	Biovitrum Advances Novel Factor VIII Long-Acting Hemophilia A Therapy into Clinical Trials
	Marketwire (Tue, Dec 15)

•	Kiobrina(TM) shows positive phase II results in preterm infants
	Marketwire (Wed, Nov 25)

•	Invitation to press- and analyst conference
	Marketwire (Thu, Nov 5)

•	The creation of a new niche specialty pharmaceutical company focused on rare diseases - with strong cash flow generation and growth potential
	Marketwire (Thu, Nov 5)

•	Biovitrum: Interim Report 1st April - 30th June, 2009
	Marketwire (Thu, Jul 23)

•	Biovitrum selects Megapharm as distributor in Israel
	Marketwire (Wed, Jul 8)

•	Biovitrum Appoints The Bank of New York Mellon as Depositary Bank
	Marketwire (Tue, Jul 7)

•	Biovitrum Interim Report 1st January - 31st March, 2009
	Marketwire (Tue, Apr 28)

•	Notice of Annual General Meeting of Biovitrum AB, 28 April 2009
	Marketwire (Fri, Mar 27)

More Headlines for BVT.ST...

BUSINESS SUMMARY

No business summary available for BVT.ST.

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

BIOVITRUM (BVT.ST)